Cargando...
Impact of Gene Patents and Licensing Practices on Access to Genetic Testing for Alzheimer’s Disease
Genetic testing for Alzheimer’s disease (AD) includes genotyping for apolipoprotein E, for late-onset AD, and three rare autosomal dominant, early-onset forms of AD associated with different genes (APP, PSEN1 and PSEN2). According to researchers, patents have not impeded research in the field, nor w...
Gardado en:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2010
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2913132/ https://ncbi.nlm.nih.gov/pubmed/20393312 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/GIM.0b013e3181d5a68e |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|